MC

543.5

-5.36%↓

SANES

6.042

-5%↓

BNP

73.98

-4.74%↓

CS.FR

39.63

-1.74%↓

ALV

353.7

-0.79%↓

MC

543.5

-5.36%↓

SANES

6.042

-5%↓

BNP

73.98

-4.74%↓

CS.FR

39.63

-1.74%↓

ALV

353.7

-0.79%↓

MC

543.5

-5.36%↓

SANES

6.042

-5%↓

BNP

73.98

-4.74%↓

CS.FR

39.63

-1.74%↓

ALV

353.7

-0.79%↓

MC

543.5

-5.36%↓

SANES

6.042

-5%↓

BNP

73.98

-4.74%↓

CS.FR

39.63

-1.74%↓

ALV

353.7

-0.79%↓

MC

543.5

-5.36%↓

SANES

6.042

-5%↓

BNP

73.98

-4.74%↓

CS.FR

39.63

-1.74%↓

ALV

353.7

-0.79%↓

Eurazeo SE

Затворен

СекторФинансови

63.45 -5.58

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

63.3

Максимум

66.25

Ключови измерители

By Trading Economics

Приходи

-105M

Продажби

104M

Дивидентна доходност

3.89

Марж на печалбата

-100.723

EBITDA

-51M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+44.93% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.89%

3.90%

Следващи печалби

10.04.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

5.1B

Предишно отваряне

69.03

Предишно затваряне

63.45

Настроения в новините

By Acuity

41%

59%

172 / 542 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Eurazeo SE Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.09.2024 г., 06:28 ч. UTC

Придобивния, сливания и поглъщания

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Сравнение с други в отрасъла

Ценова промяна

Eurazeo SE Прогноза

Ценова цел

By TipRanks

44.93% нагоре

12-месечна прогноза

Среден 100 EUR  44.93%

Висок 100 EUR

Нисък 100 EUR

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Eurazeo SE през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

N/A / 71.95Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

172 / 542 Класиране в Финансови

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil